跳至主要内容
临床试验/CTRI/2025/02/080829
CTRI/2025/02/080829尚未招募2/3 期

A randomized comparative study of ajmodadi churna and rasanadi churna in patients of amavata (rhuematoid arthritis)

J s ayurveda mahavidyalaya1 个研究点 分布在 1 个国家目标入组 40 人开始时间: 2025年2月22日最近更新:

试验速览

阶段
2/3 期
状态
尚未招募
发起方
入组人数
40
试验地点
1
主要终点
is to evaluate the effect of compared ajmodadi churna to rasnadi churna in the patients of amavata and observing changes in grade score of VAS scale of joint pain and signs and symptoms of amavata by recording them before and after the administration of treatment

研究概览

简要总结

Aamvata is a disease mentioned first time as a separate chapter in madhav nidana Ama is a substance which is produced in the body due to mandagni The sign and symptoms of amavata are mostly resembled with rheumatoid arthritis of modern science Rheumatoid arthritis is a chronic inflammatory and autoimmune disease which affects joints and connective tissues Registered patients will be randomized in two groups one group will be given ajmodadi churna and the other group will be given rasnadi churna by using the block randomization methods

研究设计

研究类型
Interventional
分配方式
Randomized
盲法
None

入排标准

年龄范围
18.00 Year(s) 至 60.00 Year(s)(—)
性别
All

入选标准

  • Patients between 18 to 60 years of age of both the genders Patient who fulfilling the diagnostic criteria signs and symptoms of amavata as well as confirmed diagnosis of rheumatoid arthritis.

排除标准

  • Patients who have developed complications of rheumatoid arthritis such as severe deformity of joints bones pleura pericardial disease or else Association of joint disease of other origin Patients with any associated comorbidities such as diabetes mellitus hypertension etc Patients on prolonged medication with immunosuppressive such as corticosteroids any other drugs within last 6 months that may have influence on the outcome of the study Pregnant or lactating women.

结局指标

主要结局

is to evaluate the effect of compared ajmodadi churna to rasnadi churna in the patients of amavata and observing changes in grade score of VAS scale of joint pain and signs and symptoms of amavata by recording them before and after the administration of treatment

时间窗: 2 weeks and 4 weeks

次要结局

  • to find out the changes in DAS 28 scale and laboratory parameters like ESR and RA factor(4 weeks)

研究者

发起方
J s ayurveda mahavidyalaya
申办方类型
Research institution and hospital
责任方
Principal Investigator
主要研究者

Dr Mishrita Tala

J S Ayurveda Mahavidyalaya

研究点 (1)

Loading locations...

相似试验